Annual Report

Overview

The report describes strong 2025 commercial performance, with total revenues of €2,517 million and Menopur becoming Ferring's first blockbuster medicine. It also highlights the company's target of reaching net-zero by 2050 and frames its ESG approach around Purpose, People and Planet. The Annual Report directs readers to the separate Sustainability Report for more detailed ESG information.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services